Inhaled Sevofluran vs Endovenous Propofol for Colonoscopy

Centro Medico Docente la Trinidad

Status

Completed

Conditions

Anesthesia

Treatments

Drug: Sevoflurane

Drug: Propofol

Study type

Interventional

Funder types

Other

Identifiers

NCT03818048

CMDLT

Details and patient eligibility

About

To compare the anesthetic efficacy of the inhalation versus intravenous technique for maintenance of sedation in patients undergoing endoscopy.

A longitudinal, randomized clinical study of 32 patients of both sexes ASA I-III, aged 18-80 years undergoing diagnostic colonoscopy, which was randomly divided into 2 groups. In both, intravenous induction with propofol (2-2.5 mg / kg) was performed, Group A remained sedated with propofol infusion (1-2 mg / kg / min); Group B by inhalation with sevoflurane at a concentration of 2 vol% through a nasal cannula with an oxygen flow.

Enrollment

32 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age between 18 and 80 years
physical status I, II and III according to the criteria of the American Society of Anesthesiology (ASA)
patients who are going to undergo diagnostic colonoscopies
patients who signed the informed consent

Exclusion criteria

Allergy or hypersensitivity to some of the reference drugs in the study
patients with proven liver disease
suspicion or confirmation of pregnancy
antecedent or risk of malignant hyperthermia
fasting less than 8 hours
patients with psychic disorders or mental incapacity that make it difficult to understand their participation in the study
patients who have acute illnesses that compromise their health for which the study cannot be performed